Venetoclax Plus Rituximab in Relapsed CLL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study
J. Clin. Oncol 2020 Sep 28;[EPub Ahead of Print], AP Kater, JQ Wu, T Kipps, B Eichhorst, P Hillmen, J D'Rozario, S Assouline, C Owen, T Robak, J de la Serna, U Jaeger, G Cartron, M Montillo, J Dubois, E Eldering, C Mellink, AM Van Der Kevie-Kersemaekers, SY Kim, B Chyla, E Punnoose, CR Bolen, ZJ Assaf, Y Jiang, J Wang, M Lefebure, M Boyer, K Humphrey, JF SeymourFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.